Alkaline phosphatase-to-albumin ratio as a novel predictor of long-term adverse outcomes in coronary artery disease patients who underwent PCI.
Xin-Ya DaiYing-Ying ZhengJun-Nan TangWei WangQian-Qian GuoShan-Shan YinJian-Chao ZhangMeng-Die ChengFeng-Hua SongZhi-Yu LiuKai WangLi-Zhu JiangLei FanXiao-Ting YueYan BaiZeng-Lei ZhangRu-Jie ZhengJin-Ying ZhangPublished in: Bioscience reports (2022)
An elevated AAR is a novel independent predictor of long-term adverse outcomes in CAD patients following PCI.
Keyphrases
- coronary artery disease
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- percutaneous coronary intervention
- prognostic factors
- acute myocardial infarction
- peritoneal dialysis
- type diabetes
- atrial fibrillation
- patient reported outcomes
- antiplatelet therapy
- st segment elevation myocardial infarction
- aortic valve
- left ventricular
- patient reported